Petr Bely

Petr Bely

Petr Bely (#3292)

  • $ 1 B
  • Pharmacy
  • Russia
  • M
  • 53 Years

About Me

Peter Bely is the founder of Russian biopharmaceutical company Promomed. Promomed sold shares on the Moscow Stock Exchange in July 2024, raising 6 billion rubles. Promomed produces Kvinsenta, generic analogue to Novo Nordisk' anti-diabetic drug Ozempic. Bely graduated from the Russian University of Medicine in 2008.
About Images

Achievements

Career Highlights

A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Petr Bely’s rise and global influence.

  • #3185   Billionaires (2026)

Wealth Growth

Net Worth Growth Over Time

Tracking Petr Bely’s net worth journey over the years, highlighting key growth phases and financial milestones.